#johnson--johnson

[ follow ]
#dividend-stocks #investing #pharmaceutical-tariffs #us-manufacturing-investment #fujifilm-diosynth
Healthcare
fromFast Company
2 weeks ago

Johnson & Johnson announces $2 billion investment to boost U.S. manufacturing as tariffs loom

Johnson & Johnson will invest $2 billion in North Carolina to expand U.S. drug manufacturing and create jobs in response to proposed import tariffs.
Healthcare
from24/7 Wall St.
1 month ago

Johnson & Johnson (NYSE: JNJ) Live Earnings Updates: Will The Dividend Champion Deliver?

Johnson & Johnson's stock is popular due to its 3.3% dividend yield and positive performance despite recent healthcare market sell-offs.
E-Commerce
fromFortune
1 month ago

Tylenol parent Kenvue has a new CEO, and he has lots of work to do to mollify activist investors

Kenvue faces challenges in growth and profitability, leading to CEO resignation and strategic review after a 4% expected drop in net sales.
#investing
from24/7 Wall St.
3 months ago
Startup companies

If You Invested $25,000 In Johnson & Johnson (JNJ) 20 Years Ago, This Is How Much Cash From Dividends You Would Have Today

from24/7 Wall St.
3 months ago
Startup companies

If You Invested $25,000 In Johnson & Johnson (JNJ) 20 Years Ago, This Is How Much Cash From Dividends You Would Have Today

more#investing
Retirement
from24/7 Wall St.
4 months ago

2 Bulletproof Dividend Stocks to Buy in May

Dividend stocks are key for wealth building, offering income and reduced volatility, especially in uncertain economic conditions.
Marketing tech
fromwww.npr.org
4 months ago

'No More Tears' author discusses Johnson & Johnson's questionable business practices

Investigative journalist Gardiner Harris critiques Johnson & Johnson's trustworthiness by linking its business practices to health crises, notably cancer from baby powder.
Public health
fromNew York Post
4 months ago

How Johnson & Johnson has somehow survived scandal after scandal

The Tylenol poisonings in 1982 sparked widespread media coverage and a major crisis for Johnson & Johnson.
[ Load more ]